APGE — Apogee Therapeutics, Inc. stock price, charts and financials

QT91Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc. (NASDAQ: APGE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
134.19
+0.08+0.06%
OverviewShort InterestFilings
APGEQT91Apogee Therapeutics, Inc.·NASDAQ
134.19+0.06%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Jul 24, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 13, 2026DEFM14ADefinitive proxy statement (merger)
Jul 10, 20264Statement of changes in beneficial ownership
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 2026PREM14APREM14A
Jun 26, 2026DEFA14AAdditional proxy soliciting materials
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 23, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 22, 20268-KCurrent report
Jun 22, 2026DEFA14AAdditional proxy soliciting materials
Jun 22, 2026DEFA14AAdditional proxy soliciting materials
Jun 22, 20268-KCurrent report
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
#1 / 25 of 289
Page
▼
/ 12